Cited by 475Acute Myocardial Infarction ResearchCoronary Interventions and DiagnosticsCardiac Ischemia and Reperfusion

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Open access

Ndrepepa, Gjin, Tiroch, Klaus, Fusaro, Massimiliano, Keta, Dritan, Seyfarth, Melchior, Byrne, Robert A., Pache, Jürgen, Alger, Patricia, Mehilli, Julinda, Schömig, Albert, Kastrati, Adnan·2010·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2009.12.054

Open this paper in CoChat — free account Open PDF

Abstract

Objectives The objective of this study was to investigate the impact of no-reflow phenomenon on 5-year mortality among patients with acute ST-segment elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PCI). This impact was also assessed in relation to infarct size.Background The impact of no-reflow on long-term mortality in patients with STEMI has been insufficiently studied.Methods This study included 1,406 patients with STEMI treated by primary PCI. No-reflow was diagnosed using angiographic criteria. Infarct size was measured with single-photon emission computed tomography imaging 7 to 14 days after the acute event. The primary outcome was 5-year mortality.Results The no-reflow phenomenon was diagnosed in 410 patients (29%). Infarct size was 15.0% (6.0% to 29.0%) of the left ventricle in the no-reflow group versus 8.0% (2.0% to 21.0%) of the left ventricle in the reflow group (p < 0.001). There were 132 deaths during follow-up. Of them, 59 deaths occurred among patients with no-reflow and 73 deaths occurred among patients with reflow (Kaplan-Meier estimates of 5-year mortality 18.2% and 9.5%, respectively; odds ratio: 2.02; 95% confidence interval: 1.44 to 2.82; p < 0.001). The Cox proportional hazards model adjusting for infarct size among other variables identified the no-reflow phenomenon as an independent correlate of 5-year mortality (hazard ratio: 1.66; 95% confidence interval: 1.17 to 2.36; p = 0.004).Conclusions In patients with STEMI treated by primary PCI, no-reflow phenomenon is a strong predictor of 5-year mortality. No-reflow phenomenon after PCI provides prognostic information that is independent of and beyond that provided by infarct size.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.12.054

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Treatment of myocardial infarction in a coronary care unit
Killip, T., & Kimball, J. T. (1967) · The American Journal of Cardiology · doi:10.1016/0002-9149(67)90023-9 · Cited by 2,071
Treatment of myocardial infarction in a coronary care unit.
Lf, T., Berman, D. A., Goldfarb, B., Mb, S., & Berman, R. S. (1969) · PubMed · Cited by 1,611
Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction
Wu, K. C., Zerhouni, E. A., Judd, R. M., Lugo-Olivieri, C. H., Barouch, L. A., Schulman, S. P., Blumenthal, R. S., & Lima, J. A. C. (1998) · Circulation · doi:10.1161/01.cir.97.8.765 · Cited by 1,356
Myocardial No-Reflow in Humans
Niccoli, G., Burzotta, F., Galiuto, L., & Crea, F. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.054 · Cited by 852
The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis
Burns, R. J., Gibbons, R. J., Yi, Q., Roberts, R. S., Miller, T. D., Schaer, G. L., Anderson, J. L., & Yusuf, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01711-9 · Cited by 493
Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow.
Ambrosio, G., Weisman, H. F., Mannisi, J. A., & Becker, L. C. (1989) · Circulation · doi:10.1161/01.cir.80.6.1846 · Cited by 466
Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction
Bolognese, L., Carrabba, N., Parodi, G., Santoro, G. M., Buonamici, P., Cerisano, G., & Antoniucci, D. (2004) · Circulation · doi:10.1161/01.cir.0000118496.44135.a7 · Cited by 426
Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade
Henriques, J. P. S., Zijlstra, F., Hof, A. W. J. V. ’., de Boer, M., Dambrink, J. E., Gosselink, M., Hoorntje, J. C. A., & Suryapranata, H. (2003) · Circulation · doi:10.1161/01.cir.0000065221.06430.ed · Cited by 399
The quantification of infarct size
Gibbons, R. J., Valeti, U. S., Araoz, P. A., & Jaffe, A. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.071 · Cited by 357

Show all 23 references

Sorted by citations

The Assessment of Endothelial Function
Flammer, A. J., Anderson, T. J., Celermajer, D. S., Creager, M. A., Deanfield, J. E., Ganz, P., Hamburg, N. M., Lüscher, T. F., Shechter, M., Taddei, S., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.093245 · Cited by 1,157
The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge
Heusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 679
Heart Failure After Myocardial Infarction: Incidence and Predictors
Jenča, D., Melenovský, V., Stehlik, J., Staněk, V., Kettner, J., Kautzner, J., Adámková, V., & Wohlfahrt, P. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13144 · Cited by 644
Coronary microvascular obstruction in acute myocardial infarction
Niccoli, G., Scalone, G., Lerman, A., & Crea, F. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv484 · Cited by 460
Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission‐ VDAC 1‐ HK 2‐ mPTP ‐mitophagy axis
Zhou, H., Zhang, Y., Hu, S., Shi, C., Zhu, P., Ma, Q., Jin, Q., Cao, F., Tian, F., & Chen, Y. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12413 · Cited by 378
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’
Padró, T., Manfrini, O., Bugiardini, R., Canty, J. M., Cenko, E., Luca, G. D., Duncker, D. J., Eringa, E. C., Koller, Á., Tousoulis, D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa003 · Cited by 298
AMPK, Mitochondrial Function, and Cardiovascular Disease
Wu, S., & Zou, M.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144987 · Cited by 286
Management of No-Reflow Phenomenon in the Catheterization Laboratory
Rezkalla, S. H., Stankowski, R. V., Hanna, J. M., & Kloner, R. A. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.11.059 · Cited by 263
Incidence and Outcomes of No-Reflow Phenomenon During Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction
Harrison, R. W., Aggarwal, A., Ou, F., Klein, L. W., Rumsfeld, J. S., Roe, M. T., & Wang, T. Y. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.015 · Cited by 248
The Coronary Circulation as a Target of Cardioprotection
Heusch, G. (2016) · Circulation Research · doi:10.1161/circresaha.116.308640 · Cited by 233
No-reflow phenomenon in the heart and brain
Kloner, R. A., King, K. S., & Harrington, M. G. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00183.2018 · Cited by 238
New Horizons in Cardioprotection
Longacre, L. S., Kloner, R. A., Arai, A. E., Baines, C. P., Bolli, R., D, E. B. M., Downey, J. M., Gibbons, R. J., Gottlieb, R. A., Heusch, G., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032698 · Cited by 216
Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial
Kelbæk, H., Høfsten, D. E., Køber, L., Helqvist, S., Kløvgaard, L., Holmvang, L., Jørgensen, E. O., Pedersen, F., Saunamäki, K. I., Backer, O. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30072-1 · Cited by 212
Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+–XO–ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways
Zhang, Y., Zhou, H., Wu, W., Chen, S., Hu, S., Yin, T., Ma, Q., Han, T., Zhang, Y., Tian, F., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.035 · Cited by 190
The no-reflow phenomenon: State of the art
Bouleti, C., Mewton, N., & Germain, S. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.09.006 · Cited by 181
CMR of microvascular obstruction and hemorrhage in myocardial infarction
Wu, K. C. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-68 · Cited by 179
Coronary no reflow
Schwartz, B. G., & Kloner, R. A. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.009 · Cited by 170
Intramyocardial haemorrhage after acute myocardial infarction
Betgem, R. P., de Waard, G. A., Nijveldt, R., Beek, A. M., Escaned, J., & van Royen, N. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.188 · Cited by 168
Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria‐Targeting Cytoprotective Peptide
Kloner, R. A., Hale, S. L., Dai, W., Gorman, R. C., Shuto, T., Koomalsingh, K. J., Gorman, J. H., Sloan, R. C., Frasier, C. R., Watson, C. A., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001644 · Cited by 155
Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury
Zhou, H., & Toan, S. (2020) · Biomolecules · doi:10.3390/biom10010085 · Cited by 136
No-Reflow Phenomenon: Maintaining Vascular Integrity
Kloner, R. A. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411405990 · Cited by 127
Usefulness of the Platelet-to-Lymphocyte Ratio in Predicting Angiographic Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction
Kurtul, A., Yarlıoğlueş, M., Murat, S. N., Ergün, G., Duran, M., Kasapkara, H. A., Demirçelik, M. B., Çetın, M., & Öcek, A. H. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.04.045 · Cited by 124
Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation
Kleinbongard, P., Böse, D., Baars, T., Möhlenkamp, S., Konorza, T. F. M., Schöner, S., Elter-Schulz, M., Eggebrecht, H., Degen, H., Haude, M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.235713 · Cited by 121
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
Gupta, S., & Gupta, M. M. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.04.006 · Cited by 120
Melatonin and cardioprotection against ischaemia/reperfusion injury: What's new? A review
Lochner, A., Marais, E., & Huisamen, B. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12490 · Cited by 116
The Utility of the Platelet–Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction
Yıldız, A., Yüksel, M., Oylumlu, M., Polat, N., Akyüz, A., Acet, H., Aydın, M., & Ülgen, M. S. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613519851 · Cited by 101
Coronary microvascular dysfunction: A review of recent progress and clinical implications
Rehan, R., Yong, A. S. C., Ng, M., Weaver, J. C., & Puranik, R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1111721 · Cited by 102
Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies
Assempoor, R., Daneshvar, M. S., Taghvaei, A., Abroy, A. S., Azimi, A., Nelson, J. R., & Hosseini, K. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02582-2 · Cited by 112
The treatment of acute myocardial infarction: the Past, the Present, and the Future
D, E. B. M. (2012) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872612438026 · Cited by 90
Usefulness of The C‐Reactive Protein/Albumin Ratio for Predicting No‐Reflow in ST ‐elevation myocardial infarction treated with primary percutaneous coronary intervention
Karabağ, Y., Çağdaş, M., Rencüzoğulları, İ., Karakoyun, S., Artaç, İ., İliş, D., Yesın, M., ÇAĞDAŞ, Ö. S., Altıntaş, B., Burak, C., et al. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12928 · Cited by 87
New and revisited approaches to preserving the reperfused myocardium
Kloner, R. A., Brown, D. A., CSETE, M. E., Dai, W., Downey, J. M., Gottlieb, R. A., Hale, S. L., & Shi, J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.102 · Cited by 86
A Randomized Study of Distal Filter Protection Versus Conventional Treatment During Percutaneous Coronary Intervention in Patients With Attenuated Plaque Identified by Intravascular Ultrasound
Hibi, K., Kozuma, K., Sonoda, S., Endo, T., Tanaka, H., Kyono, H., Koshida, R., Ishihara, T., Awata, M., Kume, T., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.03.021 · Cited by 79
Usefulness of the SYNTAX Score to Predict “No Reflow” in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
Magro, M., Nauta, S. T., Şimşek, C., Boersma, E. H., van der Heide, E., Regar, E. S., van Domburg, R. T., Zijlstra, F., Serruys, P. W. J. C., & van Geuns, R. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.013 · Cited by 78
CHA 2 DS 2 -VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention
İpek, G., Onuk, T., Karataş, M. B., Güngör, B., Ösken, A., Keskin, M., Öz, A., Tanık, O., Hayıroğlu, M. İ., Yılmaz, H. Y., et al. (2015) · Angiology · doi:10.1177/0003319715622844 · Cited by 76
The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options
Kaul, S. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.03.008 · Cited by 76
Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow
Uitterdijk, A., Yetgin, T., Hekkert, M. T. L., Sneep, S., Krabbendam‐Peters, I., van Beusekom, H. M. M., Fischer, T. M., Cornelussen, R. N., Manintveld, O. C., Merkus, D., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0508-3 · Cited by 71
Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction
Cuculi, F., Dall’Armellina, E., Manlhiot, C., Caterina, A. R. D., Colyer, S., Ferreira, V. M., Morovat, A., Prendergast, B. D., Forfar, J. C., Alp, N. J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht434 · Cited by 71
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma
Calsina, B., Castro‐Vega, L. J., Torres‐Pérez, R., Inglada‐Pérez, L., Currás-Freixes, M., Roldán‐Romero, J. M., Mančíková, V., Letón, R., Remacha, L., Santos, M., et al. (2019) · Theranostics · doi:10.7150/thno.35458 · Cited by 70
Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
Ndrepepa, G., & Kastrati, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175592 · Cited by 77
Effect of Acoustic Conditions on Microbubble-Mediated Microvascular Sonothrombolysis
Leeman, J. E., Kim, J. S., Yu, F. T. H., Chen, X., Kim, K., Wang, J., Chen, X., Villanueva, F. S., & Pacella, J. J. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2012.05.020 · Cited by 66
Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function
Lee, J., Park, B., Park, J.-H., Lim, S., Kwon, S. P., Hwang, J., Kim, H., Park, H., & Kim, B. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.08.028 · Cited by 66
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Celık, T., Balta, Ş., Demır, M., Yıldırım, A. O., Kaya, M. G., Öztürk, C., Demırkol, S., Ünlü, M., Kılıç, S., Aydın, İ., et al. (2015) · Cardiology Journal · doi:10.5603/cj.a2015.0070 · Cited by 61
Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction
Mazhar, J., Mashicharan, M., & Farshid, A. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.11.002 · Cited by 60
Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction
Hollander, M. R., de Waard, G. A., Konijnenberg, L. S. F., Putten, R. M. E. M.-V., van den Brom, C. E., Paauw, N. J., de Vries, H. E., van de Ven, P. M., Aman, J., Amerongen, G. P. V. N., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157233 · Cited by 60
The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
Süleymanoğlu, M., Rencüzoğulları, İ., Karabağ, Y., Çağdaş, M., Yesın, M., Gümüşdağ, A., Çap, M., Gök, M., & Yıldız, İ. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-019-01766-8 · Cited by 62
The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction
Balta, Ş., Celık, T., Öztürk, C., Kaya, M. G., Aparcı, M., Yıldırım, A. O., Demır, M., Kılıç, S., Aydın, İ., & Iyısoy, A. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.05.031 · Cited by 58
REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)
Huang, D., Qian, J., Ge, L., Jin, X., Jin, H., Ma, J., Liu, Z., Zhang, F., Dong, L., Wang, X., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.015 · Cited by 55
Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction
Kurtul, A., Yarlıoğlueş, M., Çelik, İ. E., Duran, M., Elçik, D., Kılıç, A., Öksüz, F., & Murat, S. N. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000301 · Cited by 55
Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Taşar, O., Karabay, A. K., Oduncu, V., & Kırma, C. (2019) · Coronary Artery Disease · doi:10.1097/mca.0000000000000726 · Cited by 53
Angiography-Derived and Sensor-Wire Methods to Assess Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction
Scarsini, R., Portolan, L., Mora, F. D., Marin, F., Mainardi, A., Ruzzarin, A., Levine, M. B., BANNING, A. P., Ribichini, F. L., Garcia, H. M. G., et al. (2023) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2023.01.017 · Cited by 52
Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Celık, T., Balta, Ş., Öztürk, C., Kaya, M. G., Aparcı, M., Yildirim, O. A., Demır, M., Ünlü, M., Demırkol, S., Kılıç, S., et al. (2015) · Angiology · doi:10.1177/0003319715605977 · Cited by 54
Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction
Galea, N., Dacquino, G. M., Ammendola, R. M., Coco, S., Agati, L., Luca, L. D., Carbone, I., Fedele, F., Catalano, C., & Francone, M. (2018) · European Radiology · doi:10.1007/s00330-018-5895-z · Cited by 52
Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?
Lønborg, J. T. (2015) · Heart · doi:10.1136/heartjnl-2015-307804 · Cited by 51
Clinical Utility and Significance of Intravascular Ultrasound and Optical Coherence Tomography in Guiding Percutaneous Coronary Interventions
Hibi, K., Kimura, K., & Umemura, S. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-1044 · Cited by 51
Myocardial Damage in Patients With Deferred Stenting After STEMI
Lønborg, J., Engstrøm, T., Ahtarovski, K. A., Nepper‐Christensen, L., Helqvist, S., Vejlstrup, N., Kyhl, K., Schoos, M. M., Ghotbi, A., Göransson, C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.601 · Cited by 51
Relaxin mitigates microvascular damage and inflammation following cardiac ischemia–reperfusion
Gao, X., Su, Y., Moore, S., Han, L., Kiriazis, H., Lu, Q., Zhao, W., Ruze, A., Fang, B., Duan, M.-J., et al. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0739-9 · Cited by 50
State of the Art
Caiazzo, G., Musci, R. L., Frediani, L., Umińska, J. M., Wańha, W., Filipiak, K. J., Kubica, J., & Navarese, E. P. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.07.001 · Cited by 54
New Method of Intracoronary Adenosine Injection to Prevent Microvascular Reperfusion Injury in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Grygier, M., Araszkiewicz, A., Lesiak, M., Janus, M., Kowal, J., Skorupski, W., Pyda, M., Mitkowski, P. P., & Grajek, S. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.12.010 · Cited by 49
Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study
Kelbæk, H., Engstrøm, T., Ahtarovski, K. A., Lønborg, J., Vejlstrup, N., Pedersen, F., Holmvang, L., Helqvist, S., Saunamäki, K. I., Jørgensen, E. O., et al. (2013) · EuroIntervention · doi:10.4244/eijv8i10a175 · Cited by 49
Mechanism and potential treatment of the “no reflow” phenomenon after acute myocardial infarction: role of pericytes and GPR39
Methner, C., Cao, Z., Mishra, A., & Kaul, S. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2021 · Cited by 49
The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction
Erkol, A., Oduncu, V., Turan, B., Kılıçgedik, A., Sırma, D., Gözübüyük, G., Karabay, C. Y., Güler, A., Dündar, C., Tigen, K., et al. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-1044-3 · Cited by 46
The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial Infarction
Maznyczka, A., Oldroyd, K. G., McCartney, P. J., McEntegart, M. B., & Berry, C. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.01.246 · Cited by 46
No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
Pantea-Roșan, L. R., Pantea, V. A., BUNGAU, S. G., Ţiţ, D. M., Behl, T., Vesa, C. M., Bustea, C., Moleriu, R. D., Rus, M., Popescu, M. I., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092956 · Cited by 46
The Reduction of Mortality in Acute Myocardial Infarction: From Bed Rest to Future Directions
Laforgia, P. L., Auguadro, C., Bronzato, S., & Durante, A. (2022) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_122_20 · Cited by 45
The role and mechanisms of microvascular damage in the ischemic myocardium
Zhao, B.-H., Ruze, A., Zhao, L., Li, Q., Tang, J. Y., Xiefukaiti, N., Gai, M.-T., Deng, A.-X., Shan, X.-F., & Gao, X.-M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04998-z · Cited by 55
Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration
Yetgin, T., Uitterdijk, A., Hekkert, M. T. L., Merkus, D., Krabbendam‐Peters, I., van Beusekom, H. M. M., Falotico, R., Serruys, P. W. J. C., Manintveld, O. C., van Geuns, R., et al. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.08.033 · Cited by 44
Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry
Papapostolou, S., Andrianopoulos, N., Duffy, S. J., Brennan, A., Ajani, A. E., Clark, D., Reid, C. M., Freeman, M., Sebastian, M., Selkrig, L. A., et al. (2018) · EuroIntervention · doi:10.4244/eij-d-17-00269 · Cited by 44
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma
Rossignoli, F., Spano, C., Grisendi, G., Foppiani, E. M., Golinelli, G., Mastrolia, I., Bestagno, M., Candini, O., Petrachi, T., Recchia, A., et al. (2019) · Theranostics · doi:10.7150/thno.27576 · Cited by 55
Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo‐controlled, clinical trial
Gögenür, I., Kücükakin, B., Jensen, L. P., Reiter, R. J., & Rosenberg, J. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12138 · Cited by 42
Effect of Delayed vs Immediate Stent Implantation on Myocardial Perfusion and Cardiac Function in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention With Thrombus Aspiration
Tang, L., Zhou, S., Hu, X., Fang, Z., & Shen, X.-Q. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.03.001 · Cited by 41
Prediction of no‐reflow and major adverse cardiovascular events with a new scoring system in STEMI patients
Bayramoğlu, A., Taşolar, H., Kaya, A., Tanboğa, İ. H., Yaman, M., Bektaş, O., Günaydın, Z. Y., & Oduncu, V. (2017) · Journal of Interventional Cardiology · doi:10.1111/joic.12463 · Cited by 41
The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters
Celık, T., Balta, Ş., Mikhailidis, D. P., Öztürk, C., Aydın, İ., Tok, D., Yıldırım, A. O., Demır, M., & Iyısoy, A. (2016) · Angiology · doi:10.1177/0003319716659193 · Cited by 40
The no-reflow phenomenon in the young and in the elderly
Cenko, E., Ricci, B., Kedev, S. A., Kalpak, O., Câlmâc, L., Vasiljević, Z., Knežević, B., Dilić, M., Miličić, D., Manfrini, O., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.209 · Cited by 39
Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study
Navarese, E. P., Frediani, L., Kandzari, D. E., Caiazzo, G., Cenname, A. M., Cortese, B., Piva, T., Muçaj, A., Tumscitz, C., Paparoni, F., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29113 · Cited by 39
Angiographic assessment of microvascular perfusion—Myocardial blush in clinical practice
Porto, I., Hamilton-Craig, C. R., Brancati, M. F., Burzotta, F., Galiuto, L., & Crea, F. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.08.009 · Cited by 38
Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
Kim, M. C., Cho, J. Y., Jeong, H. C., Lee, K. H., Park, K. H., Sim, D. S., Yoon, N. S., Youn, H. J., Kim, K. H., Hong, Y. J., et al. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.4.490 · Cited by 38
Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Cosentino, N., Campodonico, J., Pontone, G., Guglielmo, M., Trinei, M., Sandri, M. T., Riggio, D., Baggiano, A., Milazzo, V., Moltrasio, M., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.083 · Cited by 37
Prevention and Treatment of No-Reflow Phenomenon by Targeting the Coronary Microcirculation
Fehér, A., Chen, S. Y., Bagi, Z. A., & Arora, V. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0699 · Cited by 42
Predictors of left ventricular ejection function decline in young patients with ST-segment elevation myocardial infarction
Yıldız, İ., Rencüzoğulları, İ., Karabağ, Y., Karakayalı, M., Artaç, İ., & Gürevin, M. S. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220033 · Cited by 36
The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention.
Soylu, K., Yüksel, S., Gülel, O., Erbay, A. R., Meriç, M., Zengin, H., Museyibov, M., Yaşar, E., & Demircan, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.05.13 · Cited by 36
Cardiogenic shock in ACS. Part 1: prediction, presentation and medical therapy
Westaby, S., Kharbanda, R. K., & BANNING, A. P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.194 · Cited by 36
The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction
Barman, H. A., Kahyaoğlu, S., Durmaz, E., Atıcı, A., Gülşen, K., Tuğrul, S., İşleyen, H. B., Yildirim, M. R., Güngör, B., Okuyan, E., et al. (2019) · Coronary Artery Disease · doi:10.1097/mca.0000000000000781 · Cited by 36
Residual atherothrombotic material after stenting in acute myocardial infarction — An optical coherence tomographic evaluation
Magro, M., Regar, E. S., Gutiérrez‐Chico, J. L., García‐García, H. M., Şimşek, C., Schultz, C. J., Zijlstra, F., Serruys, P. W. J. C., & van Geuns, R. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.073 · Cited by 35
A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score)
Maria, G. L. D., Fahrni, G., Alkhalil, M., Cuculi, F., Dawkins, S., Wolfrum, M., Choudhury, R. P., Forfar, J. C., Prendergast, B., Yetgin, T., et al. (2016) · EuroIntervention · doi:10.4244/eijv12i10a202 · Cited by 35
Optical coherence tomography-guided percutaneous coronary intervention: a review of current clinical applications
Kurogi, K., Ishii, M., Yamamoto, N., Yamanaga, K., & Tsujita, K. (2021) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-020-00745-4 · Cited by 35
CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction
Ashoori, A., Pourhosseini, H., Ghodsi, S., Salarifar, M., Nematipour, E., Alidoosti, M., Hajizeinali, A., Nozari, Y., Amirzadegan, A., Aghajani, H., et al. (2019) · Medicina · doi:10.3390/medicina55020035 · Cited by 34
No-reflow Phenomenon in ST-segment Elevation Myocardial Infarction: Still the Achilles’ Heel of the Interventionalist
Ciofani, J. L., Allahwala, U. K., Scarsini, R., Ekmejian, A. A., BANNING, A. P., Bhindi, R., & Maria, G. L. D. (2020) · Future Cardiology · doi:10.2217/fca-2020-0077 · Cited by 34
Intravascular Ultrasound‐Guided Primary Percutaneous Coronary Intervention With Drug‐Eluting Stent Implantation in Patients With ST‐Segment Elevation Myocardial Infarction
Youn, Y. J., Yoon, J., Lee, J., Ahn, S. G., Ahn, M., Kim, J., Yoo, B. S., Lee, S., & Choe, K. (2011) · Clinical Cardiology · doi:10.1002/clc.20966 · Cited by 34
VEGF-A plasma levels are associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction
Garcia, R., Bouleti, C., Sirol, M., Logeart, D., Monnot, C., Ardidie‐Robouant, C., Caligiuri, G., Mercadier, J.-J., & Germain, S. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.067 · Cited by 34
Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention
Ayça, B., Akin, F., Çelik, Ö., Yüksel, Y., Öztürk, D., Tekiner, F., Çetin, Ş., Okuyan, E., & Dinçkal M, H. (2015) · Platelets · doi:10.3109/09537104.2014.968117 · Cited by 52
Microvascular Leakage as Therapeutic Target for Ischemia and Reperfusion Injury
Kloka, J. A., Friedrichson, B., Wülfroth, P., Henning, R., & Zacharowski, K. D. (2023) · Cells · doi:10.3390/cells12101345 · Cited by 34
SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCI
Tamis‐Holland, J. E., Abbott, J. D., Al‐Azizi, K., Barman, N., Bortnick, A. E., Cohen, M. G., Dehghani, P., Henry, T. D., Latif, F., Madjid, M., et al. (2024) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2024.102294 · Cited by 38
Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope
He, J., Bellenger, N. G., Ludman, A. J., Shore, A. C., & Strain, W. D. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2301023 · Cited by 33
Six-Year Prognostic Value of Microvascular Obstruction After Reperfused ST-Elevation Myocardial Infarction as Assessed by Contrast-Enhanced Cardiovascular Magnetic Resonance
Regenfus, M., Schlundt, C., Krähner, R., Schönegger, C., Adler, W., Ludwig, J., Daniel, W. G., & Schmid, M. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.06.034 · Cited by 33
Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
Marenzi, G., Cosentino, N., Cortinovis, S., Milazzo, V., Rubino, M., Cabiati, A., Metrio, M. D., Moltrasio, M., Lauri, G., Campodonico, J., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.09.016 · Cited by 32
The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Somuncu, M. U., Akgun, T., Çakır, M. O., Akgül, F., Serbest, N. G., Karakurt, H., Can, M., & Demir, A. R. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48413 · Cited by 32
Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
Kurtul, A., Murat, S. N., Yarlıoğlueş, M., Duran, M., Çelik, İ. E., & Kılıç, A. (2014) · Angiology · doi:10.1177/0003319714546738 · Cited by 31
Association Between Intraprocedural Thrombotic Events and Adverse Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy)
Kirtane, A. J., Sandhu, P., Mehran, R., McEntegart, M. B., Cristea, E., Brener, S. J., Xu, K., Fahy, M. P., Généreux, P., Wessler, J. D., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.034 · Cited by 30
Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention
Rafizadeh, O., Abdi, S., Peighambari, M., Basiri, H. A., & Bakhshandeh, H. (2015) · Research in Cardiovascular Medicine · doi:10.4103/2251-9572.218775 · Cited by 30
Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow
Gür, M., Türkoğlu, C., Taşkın, A., Uçar, H., Börekçi, A., Şeker, T., Gözükara, M. Y., Kaypaklı, O., Akyol, S., Selek, Ş., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.005 · Cited by 30

Authors: Ndrepepa, G., Tiroch, K., Fusaro, M., Keta, D., Seyfarth, M., Byrne, R. A., Pache, J., Alger, P., Mehilli, J., Schömig, A., & Kastrati, A.
Affiliations: Deutsches Herzzentrum München (DE)
TUM Klinikum (DE)
Corresponding author: Ndrepepa, Gjin
ORCID: Ndrepepa, Gjin
Fusaro, Massimiliano
Seyfarth, Melchior
Byrne, Robert A.
Mehilli, Julinda
Kastrati, Adnan
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2010-05
Volume: 55
Issue: 21
Pages: 2383-2389
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2009.12.054
OpenAlex: W2096751472
Cited by: 475
References: 23
Citations by year: 2026: 22 · 2025: 23 · 2024: 31 · 2023: 37 · 2022: 27 · 2021: 38 · 2020: 32 · 2019: 45 · 2018: 28 · 2017: 21 · 2016: 31 · 2015: 33 · 2014: 36 · 2013: 27 · 2012: 15
FWCI: 15.15
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1172 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
Keywords: no-reflow phenomenon, ST-elevation myocardial infarction, primary percutaneous coronary intervention, long-term mortality, infarct size, prognostic factors, coronary microvascular dysfunction, single photon emission computed tomography
MeSH terms: Aged, Cause of Death, Electrocardiography, Female, Humans, Male, Middle Aged, Myocardial Infarction, Postoperative Care, Probability, Prognosis, Retrospective Studies, Severity of Illness Index, Time Factors, Cohort Studies, Tomography, Emission-Computed, Single-Photon, Angioplasty, Balloon, Coronary, Confidence Intervals, Proportional Hazards Models, Odds Ratio, Survival Analysis, Treatment Outcome, Coronary Angiography, Risk Assessment, Statistics, Nonparametric, Kaplan-Meier Estimate, No-Reflow Phenomenon

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks